Skip to content
10-Q

Quarterly Report

EPIRUS Biopharmaceuticals, Inc.

0001558370-15-002703

← back to feed
Filed
Nov 16, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 9, 2015 24.38M sh
Capex Q3 2015 · Sep 30, 2015 $125K
Capex Q3 2015 · Sep 30, 2014 $115K
Long Term Debt Q3 2015 · Sep 30, 2015 $12.57M
Long Term Debt Q3 2015 · Dec 31, 2014 $7.28M
Short Term Debt Q3 2015 · Sep 30, 2015 $2.26M
Cash And Equivalents Q3 2015 · Sep 30, 2015 $44.42M
Cash And Equivalents Q3 2015 · Dec 31, 2014 $21.46M
Cash And Equivalents Q3 2015 · Sep 30, 2014 $23.68M
Cash And Equivalents Q3 2015 · Dec 31, 2013 $1.8M
Stockholders Equity Q3 2015 · Sep 30, 2015 $50.7M
Stockholders Equity Q3 2015 · Dec 31, 2014 $32.4M
Current Liabilities Q3 2015 · Sep 30, 2015 $21.29M
Current Liabilities Q3 2015 · Dec 31, 2014 $7.38M
Current Assets Q3 2015 · Sep 30, 2015 $50.58M
Current Assets Q3 2015 · Dec 31, 2014 $23.02M
Total Assets Q3 2015 · Sep 30, 2015 $87.07M
Total Assets Q3 2015 · Dec 31, 2014 $51.39M
Sga Expense Q3 2015 · Sep 30, 2015 $5.09M
Sga Expense Q3 2015 · Sep 30, 2015 $16.04M
Sga Expense Q3 2015 · Sep 30, 2014 $8.53M
Sga Expense Q3 2015 · Sep 30, 2014 $17.61M
Rd Expense Q3 2015 · Sep 30, 2015 $9.17M
Rd Expense Q3 2015 · Sep 30, 2015 $20.53M
Rd Expense Q3 2015 · Sep 30, 2014 $5.4M
Rd Expense Q3 2015 · Sep 30, 2014 $11.49M
Net Income Q3 2015 · Sep 30, 2015 −$13.99M
Net Income Q3 2015 · Sep 30, 2015 −$36.79M
Net Income Q3 2015 · Sep 30, 2014 −$13.94M
Net Income Q3 2015 · Sep 30, 2014 −$31.45M
Operating Income Q3 2015 · Sep 30, 2015 −$14.04M
Operating Income Q3 2015 · Sep 30, 2015 −$36.27M
Operating Income Q3 2015 · Sep 30, 2014 −$13.93M
Operating Income Q3 2015 · Sep 30, 2014 −$29.1M
Stock Repurchased Q3 2015 · Sep 30, 2014 $297K